Researchers shift focus to prevention of Alzheimer’s

News

The failures of these amyloid-reducing efforts have left researchers with two broad conclusions, said Dr. John Breitner, a professor of psychiatry at McGill University and Canada Research Chair in the prevention of dementia Tier 1. “The first is that hope is rapidly diminishing that anti-amyloid treatments will be beneficial to people who already have Alzheimer’s disease dementia,” Dr. Breitner said.

Read more: The Globe and Mail


Tags: